Ying‐Ju Lai

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

Yining Huang, Richard I. Lindley, Xiaoying Chen et al. · The Lancet · 2019 · 271 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Atrial fibrillation and its arrhythmogenesis associated with insulin resistance

Yi‐Hsin Chan, Gwo‐Jyh Chang, Ying‐Ju Lai et al. · Cardiovascular Diabetology · 2019 · 187 citations · Full text

Life Sciences, Biochemistry, Cardiology +17

Reduced BMPR2 expression induces GM-CSF translation and macrophage recruitment in humans and mice to exacerbate pulmonary hypertension

Hirofumi Sawada, Toshie Saito, Nils Nickel et al. · The Journal of Experimental Medicine · 2014 · 148 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Role of the Prostanoid EP4 Receptor in Iloprost-mediated Vasodilatation in Pulmonary Hypertension

Ying‐Ju Lai, Soni Savai Pullamsetti, Eva Dony et al. · American Journal of Respiratory and Critical Care Medicine · 2008 · 86 citations

Medicine, Molecular Biology, Pharmacology +17

miR-181b targets semaphorin 3A to mediate TGF-β–induced endothelial-mesenchymal transition related to atrial fibrillation

Ying‐Ju Lai, Feng‐Chun Tsai, Gwo‐Jyh Chang et al. · Journal of Clinical Investigation · 2022 · 69 citations · Full text

Life Sciences, Cardiology, Molecular Biology +16